Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: The EUCATAX trial

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 3, 2011, Pages 335-342

  Rodriguez, Alfredo E ^a,h   Vigo, Cesar F ^b   Delacasa, Alejandro ^c   Mieres, Juan ^a,d   Fernandez Pereira, Carlos ^a,e   Bernardi, Victor ^f   Bettinoti, Marcelo ^g   Rodriguez Granillo, Alfredo M ^h   Rodriguez Granillo, Gaston ^h   Santaera, Omar ⁱ   Curotto, Valeria ^a   Rubilar, Bibiana ^a   Tronge, Jorge ^e   Palacios, Igor F ^j   Antoniucci, David ^k  

^a Sanatorio Otamendi y Miroli   (Argentina)

^b Sanatorio Del Salvador   (Argentina)

^c Sanatorio Belgrano   (Argentina)

^d Argentina Society for Cardiovascular Interventions ^*  (Argentina)

^e IMA   (Argentina)

^f Interventional Cardiology   (Argentina)

^g Sanatorio Guemes   (Argentina)

^h Centro de Estudios en Cardiologia Intervencionista (CECI)   (Argentina)

ⁱ Argentina Society for Cardiovascular Interventions   (Argentina)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

more..

Author keywords

acute coronary syndrome (ACS); drug delivery (DDEL); percutaneous coronary intervention (PCI); quantitative coronary angiography (QCA); restenosis (RSTN)

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; POLYMER;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DEATH; DOUBLE BLIND PROCEDURE; DRUG COATING; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; GLYCOCALYX; HEART DEATH; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; STENT THROMBOSIS; STROKE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARGENTINA; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; GLYCOCALYX; HUMANS; KAPLAN-MEIER ESTIMATE; LACTIC ACID; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; POLYGLYCOLIC ACID; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79951880205     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22769     Document Type: Article

References (23)

1. Windecker S, Serruys PW, Wandel S, Buszman P, Trznadel S, Linke A, Lenk K, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Davies S, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jüni P,. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularization (LEADERS): A randomized non-inferiority trial. Lancet 2008; 372: 1163-1173.
2. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME,. Randomized study to assess the effectiveness of slow- and moderate-release polymer based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788-794. (Pubitemid 37022118)
3. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD,. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Should we cautious? Circulation 2004; 109: 701-705. (Pubitemid 38222887)
4. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ,. Late stent malapposition after DES implantation: An intravascular ultrasound analysis with long term follow up. Circulation 2006; 113: 414-419. (Pubitemid 43803203)
5. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S,. Incomplete neointimal coverage of sirolimus-eluting stents angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
6. Rodriguez AE,. Emerging drugs of coronary restenosis: Role of systemic oral agents in stent era. Expert Opin Emerging Drugs 2009; 14: 561-576.
7. Ozbek C, Mailander C, Schilling U, Bach R,. Clinical efficacy of a DES stent after an elective planned percutaneous coronary intervention under a "real life" conditions: Prospective registry (First in man data). Clin Hemorheol Microcirc 2008; 39: 311-321. (Pubitemid 352040010)
8. Hoffmann M, Horres R, Keller R, Baumann H,. Isolation and characterisation of endothelial cell surface heparan sulphate from whole bovine lung for coating of biomaterials to improve haemocompatibility. In:, Chiellini E, Sunamoto J, Migliaresi C, Ottenbrite RM, Cohn D, editors. Biomedical Polymers and Polymer Therapeutics. New York: Kluwer Academic; 2001. pp 213-226.
9. Hoffmann M, Huppertz B, Horres R, Baumann H, Keller R,. Endothelial cell surface heparan sulfate (ESHS) and synthetic heparin derivatives as hemocompatible coating for biomaterials. Materialwissenschaft und Werkstofftechnik 2001; 32: 110-115.
10. Perez G, Rodriguez-Granillo AM, Mieres J, Llaurado C, Rubilar B, Risau G, Fernandez-Pereira C, Rodriguez AE,. New coating stent design for patients with high risk coronary lesions for thrombotic events: Early and long term results of the Camouflage registry. J Invasive Cardiol 2009; 21: 378-382.
11. Ozbek C, Bay W, Jochum L, Jung F, Bach R,. Clinical and angiographic results after implantation of a passive coated coronary stents in acute myocardial infarction. J Invasive Cardiol 2008; 20: 9-13.
12. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW,. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007; 356: 989-997. (Pubitemid 46376799)
13. Rodriguez AE, Mieres J, Fernandez-Pereira C, Vigo CF, Rodriguez-Alemparte M, Berrocal D, Grinfeld L, Palacios I,. Coronary stent thrombosis in drug-eluting stent era: Insights from ERACI III trial. J Am Coll Cardiol 2006; 47: 205-207. (Pubitemid 43005187)
14. Rodriguez AE, Granada JF, Rodriguez-Alemparte M, Vigo CF, Delgado J, Fernandez-Pereira C, Pocovi A, Rodriguez-Granillo AM, Schulz D, Raizner AE, Palacios I, O'Neill W, Kaluza GL, Stone G,. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: The prospective randomized oral rapamycin in Argentina (ORAR II) study. J Am Coll Cardiol 2006; 47: 1522-1529.
15. Rodriguez AE, Grinfeld L, Fernandez-Pereira C, Mieres J, Rodriguez-Alemparte M, Berrocal D, Rodriguez-Granillo AM, Vigo CF, Russo Felsen M, O'Neill W, Palacios I,. Revascularization strategies of coronary multiple vessel disease in the drug eluting stent era: One year follow-up results of the ERACI III trial. Eurointervention. 2006; 2: 53-60.
16. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R,. A randomized comparison of sirolimus-eluting stent with a standard stent for coronary revascularisation. N Eng J Med 2002; 346: 1773-1780. (Pubitemid 34586912)
17. Rodriguez AE, Maree AO, Mieres J, Berrocal D, Grinfeld L, Fernandez-Pereira C, Curotto V, Rodriguez-Granillo A, O'Neill W, Palacios IF,. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J 2007; 28: 2118-2125. (Pubitemid 47517450)
18. Stone G, Ellis S, Cannon L, Mann JT, Greenber JD, Spriggs D, O'Saughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russel ME,. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. A randomized study. JAMA 2005; 294: 1215-1223. (Pubitemid 41352109)
19. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C,. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584-2591. (Pubitemid 44881238)
20. James SK, Stenestrand U, Lindbäck J, Carlsson J, Scherstén F, Nilsson T, Wallentin L, Lagerqvist B,. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 2009; 360: 1933-1945.
21. Serruys PW, Ruygrok P, Neuzner J, Piek JJ, Seth A, Schofer JJ, Richardt G, Wiemer M, Carrié D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J,. A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: The SPIRIT II trial. Eurointervention 2006; 2: 286-294.
22. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP,. Sirolimus vs paclitaxel eluting stents in de novo coronary artery lesions. The REALITY trial: A randomized controlled trial. JAMA 2006; 295: 895-904.
23. Grube E, Dawkins K, Guagliomi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Buellesfeld L, Koglin J, Russel MD,. Taxus VI 2 year follow up: Randomized comparison of polymer based paclitaxel eluting with bare metal stent design for treatment of long complex lesions. Eur Heart J 2007; 28: 2578-2582. (Pubitemid 350071532)